Sobi™ Discloses Payments to Healthcare Professionals and Healthcare Organisations to Increase Transparency

Sobi™ Discloses Payments to Healthcare Professionals and Healthcare Organisations to Increase Transparency

STOCKHOLM, May 31, 2018 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the company has made all payments and transfers of value to healthcare professionals and organisations from 2017 publicly available*. This includes sponsorships to attend meetings, grants and donations, speaker

Sobi Emphasises Commitment to Haemophilia Community at WFH 2018 World Congress

Sobi Emphasises Commitment to Haemophilia Community at WFH 2018 World Congress

STOCKHOLM, May 21, 2018 /PRNewswire/ — Recent data show quality-of-life improvements for patients treated prophylactically with Elocta® and Alprolix®, extended half-life haemophilia therapies. Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) will present data at the World Federation of Hemophilia (WFH) 2018 World Congress, in Glasgow,